Choice of dialysis modality in the United States

Archives of Internal Medicine

Volumn 171, Issue 2, 2011, Pages 107-109

  Kirsten L, Johansen ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEMODIALYSIS; KIDNEY FAILURE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; SURVIVAL; UNITED STATES;

HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; QUALITY OF LIFE; TREATMENT OUTCOME; UNITED STATES;

EID: 79251572032     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.370     Document Type: Editorial

References (17)

1. United States Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009.
2. Neil N, Guest S, Wong L, et al. The financial implications for Medicare of greater use of peritoneal dialysis. Clin Ther. 2009;31(4):880-888.
3. Mehrotra R, Chiu Y-W, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med. 2011;171(2):110-118. doi:10.1001/archinternmed. 2010.352.
4. Kutner NG, Zhang R, Huang Y, Wasse H. Patient awareness and initiation of peritoneal dialysis. Arch Intern Med. 2011;171(2):119-124. doi:10.1001/ archinternmed.2010.361.
5. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004;66(6):2389-2401.
6. Morton RL, Tong A, Howard K, Snelling P, Webster AC. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ. 2010;340:c112.
7. Kutner NG, Zhang R, Barnhart H, Collins AJ. Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol Dial Transplant. 2005;20(10):2159-2167. (Pubitemid 41510092)
8. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA. 2004;291(6):697-703. (Pubitemid 38543789)
9. United States Renal Data System. The USRDS Dialysis Morbidity and Mortality Study: Wave 2. Am J Kidney Dis. 1997;32(suppl 1):S67-S85.
10. Mehrotra R, Marsh D, Vonesh E, Peters V, Nissenson A. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int. 2005;68(1):378-390. (Pubitemid 43181398)
11. Mendelssohn DC, Mujais SK, Soroka SD, et al. A prospective evaluation of renal replacement therapy modality eligibility. Nephrol Dial Transplant. 2009;24(2):555-561.
12. Prichard SS. Treatment modality selection in 150 consecutive patients starting ESRD therapy. Perit Dial Int. 1996;16(1):69-72.
13. Mehrotra R, Blake P, Berman N, Nolph KD. An analysis of dialysis training in the United States and Canada. Am J Kidney Dis. 2002;40(1):152-160.
14. Heaf J. Underutilization of peritoneal dialysis. JAMA. 2004;291(6):740-742.
15. Mendelssohn DC, Mullaney SR, Jung B, Blake PG, Mehta RL. What do American nephrologists think about dialysis modality selection? Am J Kidney Dis. 2001;37(1):22-29.
16. Kutner NG, Johansen KL, Kaysen GA, et al. The Comprehensive Dialysis Study (CDS): a USRDS special study. Clin J Am Soc Nephrol. 2009;4(3):645-650.
17. Department of Health and Human Services, Center for Medicare & Medicaid Services. Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010; Corrections. http://openregs.com/regulations/view/102949/. Accessed August 13, 2010.